Hoi Tang Ma

Hoi Tang Ma

Auto-generated profile, based on publicly available information

Hoi Tang Ma

State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong Special Administrative Region of China; Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Hong Kong Special Administrative Region of China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2023 in Hepatology
Verified
Journal Article
Open access
YCYung-Tuen Chiu
Yung-Tuen Chiu
AHAbdullah Husain
Abdullah Husain
KSKaren Man-Fong Sze
Karen Man-Fong Sze
DHDaniel Wai Hung Ho
Daniel Wai Hung Ho
ESEliana Mary Senires Suarez
Eliana Mary Senires Suarez
INIrene Oi Lin Ng
Irene Oi Lin Ng
Background and Aims: Understanding the mechanisms of HCC progression and metastasis is crucial to improve early diagnosis and treatment. This study aimed to identify key molecular targets involved in HCC metastasis. Approach and Results: Using whole-transcriptome sequencing of patients’ HCCs, we identified and validated midline 1 interacting protein 1 (MID1IP1) as one of the most significantly upregulated genes in metastatic HCCs, suggesting its potential role in HCC metastasis. Clinicopathological correlation demonstrated that MID1IP1 upregulation significantly correlated with more aggressive tumor phenotypes and poorer patient overall survival rates. Functionally, overexpression of MID1IP1 significantly promoted the migratory and invasive abilities and enhanced the sphere-forming ability and expression of cancer stemness-related genes of HCC cells, whereas its stable knockdown abrogated these effects. Perturbation of MID1IP1 led to significant tumor shrinkage and reduced pulmonary metastases in an orthotopic liver injection mouse model and reduced pulmonary metastases in a tail-vein injection model in vivo. Mechanistically, SP1 transcriptional factor was found to be an upstream driver of MID1IP1 transcription. Furthermore, transcriptomic sequencing on MID1IP1-overexpressing HCC cells identified FOS-like 1 (FRA1) as a critical downstream mediator of MID1IP1. MID1IP1 upregulated FRA1 to subsequently promote its transcriptional activity and extracellular matrix degradation activity of matrix metalloproteinase MMP9, while knockdown of FRA1 effectively abolished the MID1IP1-induced migratory and invasive abilities. Conclusions: Our study identified MID1IP1 as a regulator in promoting FRA1-mediated-MMP9 signaling and demonstrated its role in HCC metastasis. Targeting MID1IP1-mediated FRA1 pathway may serve as a potential therapeutic strategy against HCC progression.

18 February 2025 in Antiviral Research
Verified
Journal Article
Closed access
DWDanny Wong
Danny Wong
NCNing Chow
Ning Chow
HMHoi Tang Ma
Hoi Tang Ma
KWKa Yan Wong
Ka Yan Wong
LMLung-Yi Loey Mak
Lung-Yi Loey Mak
MYMan-Fung Yuen
Man-Fung Yuen